<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36123878</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>37</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Effect of enterovirus 71 vaccination on the epidemiological characteristics and etiology in hospitalized children with hand-foot-and-mouth disease: A retrospective study from a tertiary children's hospital.</ArticleTitle><Pagination><StartPage>e30356</StartPage><MedlinePgn>e30356</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e30356</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000030356</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) vaccine for hand-foot-and-mouth disease (HFMD) prevention has been available for several years. However, as a new vaccine, the impact of EV71 vaccination on the epidemiology and etiology of HFMD is currently unclear. The purpose of this study was to compare and analyze the changes of epidemiological characteristics and etiology of HFMD patients after the introduction of EV71 vaccine. The data of hospitalized children with HFMD from 2014 to 2020 were collected from the case record department of a tertiary children hospital of Anhui Province. The changes of epidemiological characteristics, time distribution, disease severity and enterovirus serotypes in hospitalized children were analyzed. A total of 7373 cases of HFMD were reported during 2014 to 2020, including 634 (8.6%) severe cases. The number of cases reached the peak in 2016 (n&#x2005;=&#x2005;1783) and decreased gradually after EV71 vaccination. The results of etiological test showed the positive rate was 80.5%, in which EV71 accounted for 1599 (21.7%) and CV-A16 accounted for 1028 (13.9%) respectively. The number of patients showed a bimodal distribution throughout the year, which were April to June and October to November. The age distribution changed significantly following the introduction of EV71 vaccine. The proportion of 1-year-old group of post-vaccination was significantly higher than that of pre-vaccination (61.9% vs 50.8%, P&#x2005;&lt;&#x2005;.001). The proportion of HFMD caused by EV71 and severe cases decreased significantly after the vaccination (P&#x2005;&lt;&#x2005;.001 for both). While the comparison of epidemiological characteristics and enterovirus serotypes between unvaccinated and vaccinated cases during 2017 to 2020 showed no significant difference. The dominant enterovirus serotypes of hospitalized HFMD changed significantly after the introduction of EV71 vaccine. The proportion of severe cases decreased significantly after the vaccination, but EV71 was still a major pathogen in patients with severe HFMD. More age-appropriate children are recommended to get vaccinated to establish stronger herd immunity in the population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5919-0908</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Anhui Provincial Children's Hospital, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Qingfeng</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Biquan</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002673" MajorTopicYN="N">Child, Hospitalized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005536" MajorTopicYN="Y">Foot-and-Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>1</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36123878</ArticleId><ArticleId IdType="pmc">PMC9478296</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000030356</ArticleId><ArticleId IdType="pii">00005792-202209160-00043</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu B, Guo H, Lu H. Hand, foot, and mouth disease in mainland China. Lancet Infect Dis. 2014;14:1041.</Citation><ArticleIdList><ArticleId IdType="pubmed">25444400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadurugamuwa JL, Shaheen E. Inactivation of human enterovirus 71 and coxsackie virus A16 and hand, foot, and mouth disease. Am J Infect Control. 2011;39:788&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21565426</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, Su L, Cao L, et al. . Enterovirus genotypes causing hand foot and mouth disease in Shanghai, China: a molecular epidemiological analysis. BMC Infect Dis. 2013;13:489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015791</ArticleId><ArticleId IdType="pubmed">24148902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabanathan S, Tan le V, Thwaites L, et al. . Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: current situation and ongoing challenges. J Epidemiol Community Health. 2014;68:500&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033151</ArticleId><ArticleId IdType="pubmed">24652348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SS, Yip CC, Lau SK, et al. . Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect. 2010;138:1071&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W, et al. . An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. 2010;7:94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Teng G, Tong H, et al. . Study on risk factors for severe hand, foot and mouth disease in China. PLoS One. 2014;9:e87603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906182</ArticleId><ArticleId IdType="pubmed">24489943</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhao H, Ou R, et al. . Epidemiological and clinical characteristics of severe hand-foot-and-mouth disease (HFMD) among children: a 6-year population-based study. BMC Public Health. 2020;20:801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254654</ArticleId><ArticleId IdType="pubmed">32460823</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei M, Meng F, Wang S, et al. . 2-year efficacy, immunogenicity, and safety of vigoo enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study. J Infect Dis. 2017;215:56&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">28077584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, et al. . Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370:818&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, et al. . An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370:829&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, et al. . Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect Dis. 2014;14:308&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of China. Diagnosis and treatment guideline on hand, foot and mouth disease (2018 Version). Chin J Clin Infect Dis. 2018;11:161&#x2013;6.</Citation></Reference><Reference><Citation>Li T, Wang H, Lu Y, et al. . Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China. Vaccine. 2018;36:3772&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29776754</ArticleId></ArticleIdList></Reference><Reference><Citation>Momoki ST. Surveillance of enterovirus infections in Yokohama city from 2004 to 2008. Jpn J Infect Dis. 2009;62:471&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">19934543</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Luo L, Yan S, et al. . Clinical features for mild hand, foot and mouth disease in China. PLoS One. 2015;10:e0135503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547800</ArticleId><ArticleId IdType="pubmed">26302092</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinicola B, Conti MG, Terrin G, et al. . The protective role of maternal immunization in early life. Front Pediatr. 2021;9:638871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113393</ArticleId><ArticleId IdType="pubmed">33996688</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo ST, Chiang PS, Chao AS, et al. . Enterovirus 71 maternal antibodies in infants, Taiwan. Emerg Infect Dis. 2009;15:581&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671432</ArticleId><ArticleId IdType="pubmed">19331737</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Liang ZL, Meng FY, et al. . Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One. 2012;7:e37206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3360679</ArticleId><ArticleId IdType="pubmed">22662137</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Wu P, Wu JT, et al. . Seroprevalence of enterovirus 71 antibody among children in China: a systematic review and meta-analysis. Pediatr Infect Dis J. 2015;34:1399&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718881</ArticleId><ArticleId IdType="pubmed">26368058</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran CB, Nguyen HT, Phan HT, et al. . The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam. PLoS One. 2011;6:e21116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3134465</ArticleId><ArticleId IdType="pubmed">21765891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Zhu S, Guo X, et al. . Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol J. 2010;7:300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989968</ArticleId><ArticleId IdType="pubmed">21050463</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol. 2010;199:45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">19941005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H, Zou H, Wang Q, et al. . Short-term effect of El Ni&#xf1;o-Southern Oscillation on pediatric hand, foot and mouth disease in Shenzhen, China. PLoS One. 2013;8:e65585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720731</ArticleId><ArticleId IdType="pubmed">23935817</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Yang Z, Di B, et al. . Hand-foot-and-mouth disease and weather factors in Guangzhou, southern China. Epidemiol Infect. 2014;142:1741&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9151230</ArticleId><ArticleId IdType="pubmed">24267476</ArticleId></ArticleIdList></Reference><Reference><Citation>Altizer S, Dobson A, Hosseini P, et al. . Seasonality and the dynamics of infectious diseases. Ecol Lett. 2006;9:467&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">16623732</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson M, Drossinos Y, Stilianakis NI. Indirect transmission and the effect of seasonal pathogen inactivation on infectious disease periodicity. Epidemics. 2013;5:111&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">23746804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Feng Z, Yang Y, et al. . Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology. 2011;22:781&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3246273</ArticleId><ArticleId IdType="pubmed">21968769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashby B, Best A. Herd immunity. Curr Biol. 2021;31:R174&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33621500</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Chen Z, Zheng K, et al. . Epidemiology of hand, foot, and mouth disease before and after the introduction of enterovirus 71 vaccines in Chengdu, China, 2009-2018. Pediatr Infect Dis J. 2020;39:969&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">32433221</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity--United States, November 2007-May 2008. MMWR Morb Mortal Wkly Rep. 2008;57:697&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">18583958</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate JE, Panozzo CA, Payne DC, et al. . Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics. 2009;124:465&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">19581260</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulke-Korinek M, Rendi-Wagner P, Kundi M, et al. . Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in Austrian children. Pediatr Infect Dis J. 2010;29:319&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">19935446</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xe9;ziosi MP, Yam A, Wassilak SG, et al. . Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program. Am J Epidemiol. 2002;155:891&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11994227</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller E, Andrews NJ, Waight PA, et al. . Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11:760&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21621466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochani R, Asad A, Yasmin F, et al. . COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med. 2021;29:20&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">33664170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Wang M, Huang X, et al. . Changes in incidence of notifiable infectious diseases in China under the prevention and control measures of COVID-19. Front Public Health. 2021;9:728768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553983</ArticleId><ArticleId IdType="pubmed">34722440</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng MJ, Zhang HY, Yu LJ, et al. . Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic. Nat Commun. 2021;12:6923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626444</ArticleId><ArticleId IdType="pubmed">34836947</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S, Wang P, Li J, et al. . The indirect impact of control measures in COVID-19 pandemic on the incidence of other infectious diseases in China. Public Health Pract (Oxf). 2022;4:100278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9190177</ArticleId><ArticleId IdType="pubmed">35722540</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L, Sun M, Song S, et al. . The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-a spatiotemporal perspective in Xi&#x2019;an, northwestern China. J Med Virol. 2022;94:3121&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088661</ArticleId><ArticleId IdType="pubmed">35277880</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>